ISPOR—The Professional Society for Health Economics and Outcomes Research

#Interview - In this Clinical Leader article, ISPOR Chief Science Officer Laura Pizzi highlights how ISPOR is shaping health economics and outcomes research (#HEOR) and how improvements in data quality, trial design, and regulatory acceptance are driving real-world evidence (RWE) into the mainstream of drug development.   Read the full article: “RWE Is Growing Up, And Here's Why That Matters” https://lnkd.in/edkQR5QB #clinicalleader #RWE #healthcare

Session proposal and HEOR Impact Case Study abstract submission is open for ISPOR 2026! Showcase your thought leadership and shape the conversation at the world’s leading conference for health economics and outcomes research (HEOR). The deadline for Session proposals and HEOR Impact Case Studies submissions is December 12. Research abstract submission will open on October 31. Get details here >> https://ow.ly/gQKl50Xemxy #ISPORAnnual #HEOR #HealthEconomics #OutcomesResearch #CallForAbstracts

We are excited to welcome Dave Snowden, internationally recognized thinker, researcher, and founder of the Cynefin ® -Framework ©, as a keynote speaker at ISPOR Europe 2025! During this keynote, conference attendees will be offered a thought-provoking look at how complexity-based approaches can advance patient-centric decision making and reshape the future of health economics and outcomes research (HEOR). Learn more about the Keynote Address here: https://ow.ly/sZCW50XfWPi Explore the full conference program here: https://ow.ly/vcgE50XfWPh #ISPOREurope #HEOR #Healthcare #ComplexityScience

Connect with HEOR experts, peers, and healthcare stakeholders from around the world at ISPOR Europe 2025 (9-12 November 2025 in Glasgow, Scotland)! From classic networking opportunities to social experiences infused with learning, the program blends professional growth with meaningful engagement. Don’t miss out! >> Networking Opportunities: https://lnkd.in/eQ5y9p_y Full Program: https://lnkd.in/ec7QU-SV Check out highlights from last year's annual European conference below! #ISPOREurope #HEOR #healthcare

#Interview -Listen to this episode of the Business of Biotech podcast featuring Rob Abbott, CEO of ISPOR. He explains how startup and early-stage clinical drug development companies benefit from conducting health economics and outcomes research (HEOR), and not just with patients and commercial payers. Listen to the full episode here: https://lnkd.in/eSpNNYiX #HEOR #ISPOR #healthcare Life Science Leader

#ISPORNews ISPOR announced the recipients of its 2025 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards. ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field. Learn more: https://ow.ly/4jZy50XbgmS

HEOR Headlines in the News: - “RWE Is Growing Up, And Here's Why That Matters” (Clinical Leader) - “Can AI Help Deliver CMS’s Value-Based Care Agenda?" (Health Affairs Forefront) - “The Effect of Disease-Modifying Therapies on Brain Volume Loss and Disability Accumulation in Multiple Sclerosis” (The Lancet Regional Health Europe) Read these and more >> Visit the HEOR News Desk for curated news stories from a variety of sources: https://ow.ly/XVxR50XejWx #HEOR #healthcare #globalhealth

The Value in Health Regional Issues editorial team is excited to welcome Tianxin Pan to the Editorial Board! Tianxin will serve as Associate Editor, handling the review process for papers from the Asia region. Welcome, Tianxin!

October has been a month of momentum. Far from slowing down, the field of HEOR has leaned into some of the most important conversations yet: how we apply real-world evidence with rigor, how we can bring new frameworks to lower drug pricing and importantly, how collaboration across disciplines and industries drives meaningful progress. Next month, #ISPOREurope will be a moment to carry that energy forward. It’s where science meets policy, where dialogue becomes strategy and where a global community comes together to chart the next chapter for evidence and value. I look forward to joining so many of you in sharing insights, asking hard questions and building solutions that matter not just in theory, but in practice.

#ISPORNews Value in Health, the official journal of ISPOR, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. Learn more: https://ow.ly/VAiv50XaK4T